Cargando…

Consequences of a changing US strategy in the global HIV investment landscape

OBJECTIVE: The global fight against HIV/AIDS in Africa has long been a focus of US foreign policy, but this could change if the federal budget for 2018 proposed by the US Office of Management and Budget is adopted. We aim to inform public and Congressional debate around this issue by evaluating the...

Descripción completa

Detalles Bibliográficos
Autores principales: McGillen, Jessica B., Sharp, Alana, Honermann, Brian, Millett, Gregorio, Collins, Chris, Hallett, Timothy B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5690304/
https://www.ncbi.nlm.nih.gov/pubmed/29112075
http://dx.doi.org/10.1097/QAD.0000000000001669
_version_ 1783279578856292352
author McGillen, Jessica B.
Sharp, Alana
Honermann, Brian
Millett, Gregorio
Collins, Chris
Hallett, Timothy B.
author_facet McGillen, Jessica B.
Sharp, Alana
Honermann, Brian
Millett, Gregorio
Collins, Chris
Hallett, Timothy B.
author_sort McGillen, Jessica B.
collection PubMed
description OBJECTIVE: The global fight against HIV/AIDS in Africa has long been a focus of US foreign policy, but this could change if the federal budget for 2018 proposed by the US Office of Management and Budget is adopted. We aim to inform public and Congressional debate around this issue by evaluating the historical and potential future impact of US investment in the African HIV response. DESIGN/METHODS: We use a previously published mathematical model of HIV transmission to characterize the possible impact of a series of financial scenarios for the historical and future AIDS response across Sub-Saharan Africa. RESULTS: We find that US funding has saved nearly five million adults in Sub-Saharan Africa from AIDS-related deaths. In the coming 15 years, if current numbers on antiretroviral treatment are maintained without further expansion of programs (the proposed US strategy), nearly 26 million new HIV infections and 4.4 million AIDS deaths may occur. A 10% increase in US funding, together with ambitious domestic spending and focused attention on optimizing resources, can avert up to 22 million HIV infections and save 2.3 million lives in Sub-Saharan Africa compared with the proposed strategy. CONCLUSION: Our synthesis of available evidence shows that the United States has played, and could continue to play, a vital role in the global HIV response. Reduced investment could allow more than two million avoidable AIDS deaths by 2032, whereas continued leadership by the United States and other countries could bring UNAIDS targets for ending the epidemic into reach.
format Online
Article
Text
id pubmed-5690304
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-56903042017-11-29 Consequences of a changing US strategy in the global HIV investment landscape McGillen, Jessica B. Sharp, Alana Honermann, Brian Millett, Gregorio Collins, Chris Hallett, Timothy B. AIDS Fast Track OBJECTIVE: The global fight against HIV/AIDS in Africa has long been a focus of US foreign policy, but this could change if the federal budget for 2018 proposed by the US Office of Management and Budget is adopted. We aim to inform public and Congressional debate around this issue by evaluating the historical and potential future impact of US investment in the African HIV response. DESIGN/METHODS: We use a previously published mathematical model of HIV transmission to characterize the possible impact of a series of financial scenarios for the historical and future AIDS response across Sub-Saharan Africa. RESULTS: We find that US funding has saved nearly five million adults in Sub-Saharan Africa from AIDS-related deaths. In the coming 15 years, if current numbers on antiretroviral treatment are maintained without further expansion of programs (the proposed US strategy), nearly 26 million new HIV infections and 4.4 million AIDS deaths may occur. A 10% increase in US funding, together with ambitious domestic spending and focused attention on optimizing resources, can avert up to 22 million HIV infections and save 2.3 million lives in Sub-Saharan Africa compared with the proposed strategy. CONCLUSION: Our synthesis of available evidence shows that the United States has played, and could continue to play, a vital role in the global HIV response. Reduced investment could allow more than two million avoidable AIDS deaths by 2032, whereas continued leadership by the United States and other countries could bring UNAIDS targets for ending the epidemic into reach. Lippincott Williams & Wilkins 2017-11-28 2017-11-09 /pmc/articles/PMC5690304/ /pubmed/29112075 http://dx.doi.org/10.1097/QAD.0000000000001669 Text en Copyright © 2017 The Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0.
spellingShingle Fast Track
McGillen, Jessica B.
Sharp, Alana
Honermann, Brian
Millett, Gregorio
Collins, Chris
Hallett, Timothy B.
Consequences of a changing US strategy in the global HIV investment landscape
title Consequences of a changing US strategy in the global HIV investment landscape
title_full Consequences of a changing US strategy in the global HIV investment landscape
title_fullStr Consequences of a changing US strategy in the global HIV investment landscape
title_full_unstemmed Consequences of a changing US strategy in the global HIV investment landscape
title_short Consequences of a changing US strategy in the global HIV investment landscape
title_sort consequences of a changing us strategy in the global hiv investment landscape
topic Fast Track
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5690304/
https://www.ncbi.nlm.nih.gov/pubmed/29112075
http://dx.doi.org/10.1097/QAD.0000000000001669
work_keys_str_mv AT mcgillenjessicab consequencesofachangingusstrategyintheglobalhivinvestmentlandscape
AT sharpalana consequencesofachangingusstrategyintheglobalhivinvestmentlandscape
AT honermannbrian consequencesofachangingusstrategyintheglobalhivinvestmentlandscape
AT millettgregorio consequencesofachangingusstrategyintheglobalhivinvestmentlandscape
AT collinschris consequencesofachangingusstrategyintheglobalhivinvestmentlandscape
AT halletttimothyb consequencesofachangingusstrategyintheglobalhivinvestmentlandscape